F.Biotechnology Dis.Fd.F USD
LU1573964712
F.Biotechnology Dis.Fd.F USD/ LU1573964712 /
| NAV2024-11-06 |
Chg.+0.2100 |
Type of yield |
Investment Focus |
Investment company |
| 14.1000USD |
+1.51% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Investment goal
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Index |
| Business year start: |
07-01 |
| Last Distribution: |
- |
| Depository bank: |
J.P. Morgan SE, Niederlassung Luxemburg |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, Czech Republic |
| Fund manager: |
Evan McCulloch, Akiva Felt |
| Fund volume: |
1.53 bill.
USD
|
| Launch date: |
2017-04-21 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
0.00% |
| Max. Administration Fee: |
1.50% |
| Minimum investment: |
1,000.00 USD |
| Deposit fees: |
0.14% |
| Redemption charge: |
3.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Franklin Templeton |
| Address: |
Schottenring 16, 2.OG, 1010, Wien |
| Country: |
Austria |
| Internet: |
www.franklintempleton.at
|
Assets
| Stocks |
|
96.74% |
| Cash |
|
0.22% |
| Others |
|
3.04% |
Countries
| United States of America |
|
78.32% |
| Netherlands |
|
5.70% |
| United Kingdom |
|
4.09% |
| Denmark |
|
3.17% |
| Ireland |
|
2.63% |
| Cayman Islands |
|
0.88% |
| France |
|
0.87% |
| Canada |
|
0.73% |
| Germany |
|
0.35% |
| Cash |
|
0.22% |
| Others |
|
3.04% |
Branches
| Pharma/Biotechnology |
|
92.60% |
| Healthcare services |
|
4.14% |
| Cash |
|
0.22% |
| Others |
|
3.04% |
